Brokerages Set Victrex plc (LON:VCT) Target Price at GBX 663.33

Victrex plc (LON:VCT) has received an average rating of “Hold” from the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is GBX 663.33.

A number of research analysts have issued reports on VCT shares. Jefferies Financial Group reissued a “hold” rating and issued a GBX 595 target price on shares of Victrex in a research note on Tuesday, July 7th. UBS Group reiterated a “sell” rating and set a GBX 575 price objective on shares of Victrex in a report on Monday, May 11th. Canaccord Genuity Group lowered Victrex to a “buy” rating and set a GBX 725 price objective for the company. in a research report on Friday, May 15th. Finally, Berenberg Bank increased their target price on Victrex from GBX 600 to GBX 680 and gave the stock a “hold” rating in a research note on Wednesday, July 8th.

Victrex Stock Up 2.8%

Shares of LON VCT opened at GBX 765 on Friday. Victrex has a 52-week low of GBX 515 and a 52-week high of GBX 768. The company has a debt-to-equity ratio of 21.30, a quick ratio of 1.99 and a current ratio of 2.35. The stock has a market cap of £666.51 million, a P/E ratio of -34.15, a P/E/G ratio of 1.92 and a beta of 0.77. The firm has a 50 day moving average price of GBX 641.26 and a 200 day moving average price of GBX 642.07.

Victrex (LON:VCT) last posted its earnings results on Monday, May 11th. The company reported GBX 17.20 earnings per share for the quarter. The company had revenue of £147.10 million for the quarter. Victrex had a negative net margin of 6.70% and a negative return on equity of 4.95%. Analysts expect that Victrex will post 73.1078905 EPS for the current year.

About Victrex

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.